Joint Formulary & PAD

Amisulpride - Schizophrenia and other psychoses

You are here : Home > Formulary Search > Amisulpride - Schizophrenia and other psychoses

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral solution
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Second line treatment option in the management of schizophrenia once metabolic syndrome has been identified.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Amisulpride
Indication :
Schizophrenia and other psychoses
Group Name :
Keywords :
antipsychotics
Brand Names Include :
Important Information :

Initiation by a Mental Health specialist and stabilisation for at least 1 month before any request to transfer prescribing responsibility.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

03 Sep 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the length of prescribing of anti-psychotics by the specialist team at Surrey & Borders Partnership NHS Foundation Trust as:

 SABP specialist initiation and prescribing for at least 1 month and until the patient is stabilised on treatment prior to transfer of care to primary care.

Where a stabilised patient requires a simple, non-complex and non-urgent dose adjustment, this can be managed in primary care on recommendation by the specialist team.

Other Indications

Below are listed other indications that Amisulpride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Schizophrenia and other psychoses.